Austrianova Singapore Pte Ltd

Austrianova is a biotechnology company headquartered in Singapore that specializes in cell encapsulation technology. The company has developed proprietary platforms, including Cell-in-a-Box and Bac-in-a-Box, which create porous capsules around living cells, bacteria, or yeast. This encapsulation protects the contents from external environments while allowing for the free diffusion of nutrients, waste, and synthesized biological molecules. These technologies are designed to facilitate the storage, transport, and therapeutic application of living cells for various medical and biological uses. In addition to its encapsulation platforms, the company provides comprehensive cell R&D services, including standardized allogenic cell therapy development, cell line engineering, and GMP-compliant cell banking.

By providing these technologies and services, Austrianova supports partners in the pharmaceutical and biotechnology sectors in developing innovative therapeutics, including treatments for cancer and age-related conditions. The company’s solutions enable the use of standardized cell products that do not require a patient's own cells, potentially streamlining clinical applications. Austrianova’s work is supported by extensive peer-reviewed research and international collaborations. The company maintains an international presence, with operations in Singapore and a European base in Germany, serving as a B2B partner for firms requiring expert cell biology services and specialized manufacturing capabilities under high quality and safety standards.